Sanare Bioscience was born out of the network and experiences developed by Founder, Jack Donaldson IV, over a period of fifteen years spent in healthcare consulting.
During this time, Jack developed a network of hundreds of physicians and researchers, while also encountering problems in pharmaceutical supply chains, and areas of research that are traditionally underfunded. This sparked the vision for a pharmaceutical research company that focused on two areas – bridging gaps in research and funding, and unlocking value for healthcare providers through better pharmaceutical supply chains.
The result is Sanare Bioscience, an expertise-filled team that brings value through research, development and provider distribution of critical drugs that improve lives.
Sanare Life Sciences’ flagship product will be a toxicity related product that will showcase our capabilities. Our purpose is to discover, develop, produce and market drugs that improve outcomes. Our areas of focus are:
Partner with Sanare Bioscience
We actively seek out new relationships with physicians, researchers, trial participants and investors.
If you’re interested in learning more about partnership, reach out below.